NTLA Snapshot
Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.
VALUATION DATA
Market Capitalization$2,653,498,000
Price to Sales5.00
Earnings per Share$-5.4200
PE RatioNone
PRICE DATA
Most Recent Close$27.5100
52 Week High$73.15
52 Week Low$2.471
50-Day Moving Average$49.57
200-Day Moving Average$-3.551
All data are from Alpha Vantage as of today. For more infomation on NTLA see Stock Dividend, Valuation, Price and Financial Data for Investors